Divi#39;s Labs set for big margin boost but valuations expensive, says MOFSL
- Hot Stocks
admin
- 0
- 1 minute read
The capital expenditure of Rs 2,800 crore incurred at its existing sites would cater to the pharma company’s growth over the next 12-24 months, while the spend at the Kakinada unit would drive growth beyond FY25, the brokerage firm has said
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1681118613-f3652ffa5f3042ee8d4bd5c723050a5e.jpg "Should I Invest or Pay off My Mortgage?")
:max_bytes(150000):strip_icc():format(jpeg)/StudentinLibrary-c1c5d2a70c1042e8a324245af41af29c.jpg "9 Ways Student Debt Can Derail Your Life")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2155192214-7a7d4b96bdf044e6b3f3d25e3ad451bf.jpg "These 9 States Boast the Lowest Unemployment Rates—Does Yours Make the Cut?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1359420138-89306d2300384dc5877ff088997e77dd.jpg "<div>Feeling Stressed About the Future of Your Student Loans? I'm a Financial Advisor—Here's What You Need to Know</div>")
:max_bytes(150000):strip_icc():format(jpeg)/homestaging-026b9ef577364870862916d4db364767.jpg "Is Professional Home Staging Worth the Cost?")